Abstract
Cerebrovascular diseases are an important cause of morbidity and mortality worldwide. Endovascular treatment has emerged as a minimally invasive approach to treat cerebrovascular diseases and possibly intracranial neoplasms. Practice patterns for selection of patients for endovascular treatment are continuously being modified on the basis of new information derived from clinical studies. In this review, I discuss the various endovascular treatments for diseases such as ischaemic stroke, carotid and intracranial stenosis, intracranial aneurysms, arteriovenous malformations, malignant gliomas, and meningiomas.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 804-813 |
| Number of pages | 10 |
| Journal | Lancet |
| Volume | 363 |
| Issue number | 9411 |
| DOIs | |
| State | Published - Mar 6 2004 |
Bibliographical note
Funding Information:A Qureshi has received grant support from Boston Scientific, Cordis Therapeutics, Cor Therapeutics, Centocor therapeutics, C R Bard, and San Francisco Science/PICS. He has also received consultant fees from EndoTex Interventional Systems and Boston Scientific and an honorarium from Boehringer Ingelheim.
